Zdrowie i gospodarka · 14/06/2017

FDA Requests Public Comment on Proposed Collection of Information for Prescription Drug Promotion Disclosures

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to prescription drug promotion disclosures, as required by the Paperwork Reduction Act of 1995, and will accept comments for 60 days.